Lovastatin Tablet
Product Images NDC 68071-3622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68071-3622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)
This text provides information on the proportion of participants without acute major coronary events as the primary endpoint of the study. It shows a significant 87% risk reduction with a p-value less than 0.0009. The data is presented over the years of follow-up.*
FDA Label Image

Pdp (68071 3622 1)

Pdp (68071 3622 1)
This text appears to be describing a pharmaceutical product named Lovastatin 10. It includes details such as the manufacturer (NuCare Pharmaceuticals, Inc.), dosage information, NDC numbers, expiration dates, quantity (100 tablets), and a warning to keep the product out of reach of children and store it at a controlled temperature. It also advises to seek medical advice for side effects and provides contact information for reporting side effects to the FDA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.